Numata K, Ono Y, Iguchi K, Uchiyama M, et al. Prognostic significance of modified Glasgow Prognostic Score in patients undergoing FOLFOXIRI plus bevacizumab therapy for advanced or metastatic colorectal cancer. Oncology 2025 May 26:1-22. doi: 10.1159/000546260.
PMID: 40418922